Detalles de la búsqueda
1.
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
Oncologist
; 29(1): e118-e130, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37603442
2.
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Oncologist
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520745
3.
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
J Transl Med
; 22(1): 242, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443899
4.
Vascular/epithelial changes as late sequelae after recovery from SARS-COV-2 infection: an in-vivo comparative study.
Histopathology
; 83(2): 229-241, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37102989
5.
Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need.
Int J Mol Sci
; 24(10)2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240224
6.
Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
Int J Mol Sci
; 24(12)2023 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373267
7.
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Br J Cancer
; 127(3): 383-393, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264788
8.
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Br J Cancer
; 127(11): 2034-2042, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36175621
9.
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome.
Oncologist
; 27(2): e199-e202, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641202
10.
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Oncologist
; 27(6): e484-e493, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429394
11.
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Oncologist
; 27(2): 87-e115, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641222
12.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Future Oncol
; 18(7): 771-779, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35068173
13.
Combi-TED: a new trial testing Tedopi® with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line.
Future Oncol
; 18(40): 4457-4464, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946237
14.
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer.
Int J Mol Sci
; 23(8)2022 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35456982
15.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499874
16.
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification.
Cytokine
; 146: 155622, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34153874
17.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
Future Oncol
; 17(19): 2513-2527, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33988036
18.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
19.
Metabolic rewiring and redox alterations in malignant pleural mesothelioma.
Br J Cancer
; 122(1): 52-61, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31819191
20.
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer.
Br J Cancer
; 123(1): 81-91, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32376889